SAN DIEGO, March 29, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its flagship product Real Scientific Hemp Oil™ (RSHO™) was featured on Emmy® Award-winning daytime talk show CBS’ The Doctors on Tuesday, March 27, 2018.
The product featured, Real Scientific Hemp Oil™, is a pure non-GMO hemp oil, unmodified and sourced straight from the hemp plant. RSHO™ is extracted from hemp using supercritical CO2 and Triple Lab Tested® and is cultivated free of chemical fertilizers, pesticides or herbicides in Northern Europe.
“We’re very pleased with this national TV segment that features our CBD hemp oil product and talks about the health and wellness benefits of CBD,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We are dedicated to educating our customers about the many uses of cannabis and how it interacts with the body’s endocannabinoid system.”
Medical Marijuana, Inc. subsidiary HempMeds®, the company that sells RSHO™, was the first company to ever bring hemp-based CBD oil products to market in the U.S. in 2012 and was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations of Brazil, Mexico and Paraguay.
Visit www.thedoctorstv.com to watch the segment and learn more.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.